Literature DB >> 24090823

Harnessing cognitive neuroscience to develop new treatments for improving cognition in schizophrenia: CNTRICS selected cognitive paradigms for animal models.

Holly Moore1, Mark A Geyer, Cameron S Carter, Deanna M Barch.   

Abstract

Over the past two decades, the awareness of the disabling and treatment-refractory effects of impaired cognition in schizophrenia has increased dramatically. In response to this still unmet need in the treatment of schizophrenia, the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia (CNTRICS) initiative was developed. The goal of CNTRICS is to harness cognitive neuroscience to develop a brain-based set of tools for measuring cognition in schizophrenia and to test new treatments. CNTRICS meetings focused on development of tasks with cognitive construct validity for use in both human and animal model studies. This special issue presents papers discussing the cognitive testing paradigms selected by CNTRICS for animal model systems. These paradigms are designed to measure cognitive constructs within the domains of perception, attention, executive function, working memory, object/relational long-term memory, and social/affective processes.
Copyright © 2013. Published by Elsevier Ltd.

Entities:  

Keywords:  Behavior; CNTRICS; Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia; Mouse; Non-human primate; Psychopharmacology; Psychosis; Rat

Mesh:

Year:  2013        PMID: 24090823      PMCID: PMC3965347          DOI: 10.1016/j.neubiorev.2013.09.011

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  21 in total

1.  Imaging biomarkers for treatment development for impaired cognition: report of the sixth CNTRICS meeting: Biomarkers recommended for further development.

Authors:  Cameron S Carter; Deanna M Barch
Journal:  Schizophr Bull       Date:  2011-09-12       Impact factor: 9.306

Review 2.  Schizophrenia in translation: dissecting motivation in schizophrenia and rodents.

Authors:  Eleanor H Simpson; James A Waltz; Christoph Kellendonk; Peter D Balsam
Journal:  Schizophr Bull       Date:  2012-09-26       Impact factor: 9.306

Review 3.  Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS.

Authors:  Michael F Green; Robert S Kern; Robert K Heaton
Journal:  Schizophr Res       Date:  2004-12-15       Impact factor: 4.939

4.  Rethinking schizophrenia.

Authors:  Thomas R Insel
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

Review 5.  Cognitive impairment associated with schizophrenia: a review of the humanistic burden.

Authors:  Helen Kitchen; Diana Rofail; Louise Heron; Pat Sacco
Journal:  Adv Ther       Date:  2012-02-10       Impact factor: 3.845

Review 6.  CNTRICS final task selection: control of attention.

Authors:  Keith H Nuechterlein; Steven J Luck; Cindy Lustig; Martin Sarter
Journal:  Schizophr Bull       Date:  2009-01       Impact factor: 9.306

Review 7.  Cognitive enhancement in schizophrenia: pharmacological and cognitive remediation approaches.

Authors:  Philip D Harvey; Christopher R Bowie
Journal:  Psychiatr Clin North Am       Date:  2012-07-15

8.  Schizophrenia, IX: Cognition in schizophrenia--the MATRICS initiative.

Authors:  Stephen R Marder; Wayne Fenton; Kenneth Youens
Journal:  Am J Psychiatry       Date:  2004-01       Impact factor: 18.112

9.  The touchscreen operant platform for assessing executive function in rats and mice.

Authors:  Adam C Mar; Alexa E Horner; Simon R O Nilsson; Johan Alsiö; Brianne A Kent; Chi Hun Kim; Andrew Holmes; Lisa M Saksida; Timothy J Bussey
Journal:  Nat Protoc       Date:  2013-09-19       Impact factor: 13.491

10.  The touchscreen operant platform for testing working memory and pattern separation in rats and mice.

Authors:  Charlotte A Oomen; Martha Hvoslef-Eide; Christopher J Heath; Adam C Mar; Alexa E Horner; Timothy J Bussey; Lisa M Saksida
Journal:  Nat Protoc       Date:  2013-09-19       Impact factor: 13.491

View more
  21 in total

1.  Wet or dry: translatable "water mazes" for mice and humans.

Authors:  Kerin K Higa; Jared W Young; Mark A Geyer
Journal:  J Clin Invest       Date:  2016-01-19       Impact factor: 14.808

2.  Associations and hallucinations in mice and men.

Authors:  Dominic M Dwyer
Journal:  Learn Behav       Date:  2018-09       Impact factor: 1.986

Review 3.  The NEWMEDS rodent touchscreen test battery for cognition relevant to schizophrenia.

Authors:  M Hvoslef-Eide; A C Mar; S R O Nilsson; J Alsiö; C J Heath; L M Saksida; T W Robbins; T J Bussey
Journal:  Psychopharmacology (Berl)       Date:  2015-07-24       Impact factor: 4.530

4.  Effects of the T-type calcium channel antagonist Z944 on paired associates learning and locomotor activity in rats treated with the NMDA receptor antagonist MK-801.

Authors:  Andrew J Roebuck; Wendie N Marks; Max C Liu; Nimra B Tahir; Nadine K Zabder; Terrance P Snutch; John G Howland
Journal:  Psychopharmacology (Berl)       Date:  2018-09-24       Impact factor: 4.530

Review 5.  Translating advances in the molecular basis of schizophrenia into novel cognitive treatment strategies.

Authors:  Colm M P O'Tuathaigh; Paula M Moran; Xuechu C Zhen; John L Waddington
Journal:  Br J Pharmacol       Date:  2017-08-03       Impact factor: 8.739

6.  Cognition in schizophrenia: Past, present, and future.

Authors:  Michael F Green; Philip D Harvey
Journal:  Schizophr Res Cogn       Date:  2014-03

7.  Drug development: The modelling challenge.

Authors:  Alla Katsnelson
Journal:  Nature       Date:  2014-04-03       Impact factor: 49.962

8.  Development and testing of a web-based battery to remotely assess cognitive health in individuals with schizophrenia.

Authors:  Bruno Biagianti; Melissa Fisher; Benjamin Brandrett; Danielle Schlosser; Rachel Loewy; Mor Nahum; Sophia Vinogradov
Journal:  Schizophr Res       Date:  2019-02-04       Impact factor: 4.939

9.  Understanding the Profile of Cancer-Related Cognitive Impairments: A Critique of Meta-Analyses.

Authors:  Todd S Horowitz; Melissa Treviño; Ingrid M Gooch; Korrina A Duffy
Journal:  J Natl Cancer Inst       Date:  2019-10-01       Impact factor: 13.506

10.  New horizons in schizophrenia treatment: autophagy protection is coupled with behavioral improvements in a mouse model of schizophrenia.

Authors:  Avia Merenlender-Wagner; Zeev Shemer; Olga Touloumi; Roza Lagoudaki; Eliezer Giladi; Annie Andrieux; Nikolaos C Grigoriadis; Illana Gozes
Journal:  Autophagy       Date:  2014       Impact factor: 16.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.